A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease

NCT06900010 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Bullous Disease

Interventions

BIOLOGICAL: CM336 Injection

Sponsor

Shandong First Medical University